Hhm Wealth Advisors, LLC Organon & Co. Transaction History

Hhm Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$10.95 - $17.32 $87 - $138	-8 Reduced 61.54%	5 $0
Q3 2023 Nov 03, 2023	SELL	$16.59 - $23.77 $99 - $142	-6 Reduced 31.58%	13 $0
Q4 2022 Jan 19, 2023	SELL	$23.31 - $28.61 $116 - $143	-5 Reduced 20.83%	19 $0
Q3 2022 Nov 04, 2022	SELL	$23.4 - $34.25 $1,170 - $1,712	-50 Reduced 67.57%	24 $1,000
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $23,020 - $29,756	-756 Reduced 91.08%	74 $3,000
Q4 2021 Feb 03, 2022	SELL	$28.67 - $37.13 $630 - $816	-22 Reduced 2.58%	830 $25,000
Q3 2021 Nov 02, 2021	SELL	$28.63 - $35.64 $229 - $285	-8 Reduced 0.93%	852 $28,000
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $24,467 - $32,680	860 New	860 $26,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Hhm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hhm Wealth Advisors, LLC with notifications on news.